Mucormycosis, One Month after Recovery from COVID-19: A Case Report

There are increasing case reports of mucormycosis in patient with coronavirus disease 2019 (COVID-19). Herein we describe the first case of mucormycosis during COVID-19 treatment in Razi teaching hospital.The patient was a 73 years old woman with a history of chronic kidney disease, diabetes mellitus, hypertension, and dyslipidemia referred to the emergency department with clinical presentation of COVID-19. The patient was admitted and, the diagnosis was confirmed with a positive PCR test, treatment and medications started for the patient on the fifth day of admission. The patient presented a headache and pain in her upper jaw. Physical examination showed fever, erythema, and tenderness in the right cheek. Emergency biopsy and culture from sinus by subsection to mucormycosis conducted. On CT-scan of the brain, orbits, and paranasal sinuses reveal soft tissue swelling and development of fungal invasion to the right side of the face, the diagnosis confirmed by the positive result of biopsy and culture. Despite Anti-fungal treatment with Amphotericin B, patient developed severe diarrhea and became hemodynamically unstable. In the stool analysis, Strongyloides stercoralis was reported. Unfortunately, patient was expired on day thirty-two of this admission.Clinicians should consider mucormycosis and its complications after COVID-19 treatment in diabetic and immunocompromised patients